Skandinaviska Enskilda Banken (SEB)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-64,273	Closed	-$20.3M	–	973
2023 Q4	$20.3M	Buy	64,273 +55,374	+622%	+$10.8M	0.12%	170
2023 Q3	$1.5M	Buy	8,899 +2,398	+37%	+$451K	0.01%	606
2023 Q2	$1.41M	Buy	6,501 +3,347	+106%	+$717K	0.01%	634
2023 Q1	$573K	Buy	+3,154	New	+$603K	﹤0.01%	762
2020 Q3	–	Sell	-400	Closed	-$45K	–	1129
2020 Q2	$45K	Buy	+400	New	+$34.8K	﹤0.01%	997

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s KRTX Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 64,273 shares — an estimated $20.3M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in KRTX in Q2 2020 and held it in 5 quarters. The position peaked at $20.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Skandinaviska Enskilda Banken (SEB) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 64,273 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $20.3M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Skandinaviska Enskilda Banken (SEB)'s Karuna Therapeutics, Inc. Common Stock position peaked at $20.3M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.